Navigation Links
Improved governance needed to realize nanotech's benefits
Date:4/23/2008

WASHINGTON - Without an improved governance structure, the benefits of nanotechnology may be difficult to fully realize because the public will not trust the cutting-edge technology, says David Rejeski, director of the Project on Emerging Nanotechnologies (PEN). Rejeski testifies on Thursday, April 24, before the Senate subcommittee on technology and innovation.

Public trust is the dark horse in nanotechnologys future, states Rejeski in his testimony. If government and industry do not work to build public confidence in nanotechnology, consumers may reach for the No-Nano label in the future and investors will put their money elsewhere. Public perceptions about risksreal and perceivedcan have large economic impacts. For example, the European Unions ban on genetically modified foods, driven largely by public concerns, cost American farmers an estimated $300 million annually in lost sales and much more in products that never made it to the marketplace.

Congressional lawmakers are currently discussing amendments to and reauthorization of the 21st Century Nanotechnology Research & Development Act, which helps sets the roadmap for the annual $1.5 billion federal spending on nanotechnology research that is vital to ensuring the technologys success.

What: Senate Commerce, Science & Transportation Committee Subcommittee on Science, Technology and Innovation hearing National Nanotechnology Initiative: Charting the Course for Reauthorization

When: April 24, 2008, 2:30 p.m.

Where: Russell Senate Office Building Room 253, Washington, DC

Who: David Rejeski directs the Project on Emerging Nanotechnologies. For the past eight years, he has also been the Director of the Foresight and Governance Project at the Woodrow Wilson Center. He has held various positions at the White House Council on Environmental Quality (CEQ), the White House Office of Science and Technology (OSTP), and the Environmental Protection Agency (EPA). He
'/>"/>

Contact: Alex Parlini
alex.parlini@wilsoncenter.org
301-768-8366
Project on Emerging Nanotechnologies
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. New Robotic Imaging Technology Holds Promise of Improved Cancer Care
2. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
3. Diagnostic Turnaround Improved by 600% Through Interoperability
4. Improved wettability of carbon nanotubes opens the door to new possibilities
5. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
6. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
7. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
8. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
9. Farmers Across the U.S. Realize Double-Digit Yield Advantage From DEKALB(R) Corn Seeds With Triple-Stacked Traits
10. Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storage
11. Study Finds Widespread Vitamin and Mineral Use Among Cancer Survivors, Although Benefits of Such Use Remain Unclear
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... 3 JourneyLite of Houston, LLC announced ... patients a second surgical option, vertical sleeve gastrectomy ... it currently performs. The first sleeve gastrectomy procedure at ... St. Laurent, MD on October 20, 2009. The ...
(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. ... on its European commercial launch of MuGard, an FDA ... of radiation treatment and chemotherapy. MuGard is commercially launched ... the UK, Germany, Italy, Norway, Greece and Sweden. Access ...
(Date:12/3/2009)... Shire plc (LSE: SHP, Nasdaq: SHPGY ), the ... of five lots and voluntary market withdrawal of one ... . Shire is taking this action because some Daytrana ... not meet their release liner removal specification, and as ...
(Date:12/3/2009)... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, has ... B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... amount per share equal to the quotient of (a) $3.00 ...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5
... LEUVEN, Belgium, August 28 , - Professor ... Board and,Scientific Advisor, ThromboGenics NV (Euronext Brussels: ... eye disease, vascular disease and cancer,announces today that ... been appointed to succeed Professor Desire Collen as ...
... ENGLEWOOD, Colo., Aug. 28 Inc.com has again included,Baxa ... private,companies in the country. Baxa ranked number 4,611 and ... list. The company has grown steadily,since its founding in ... Colorado headquarters and UK subsidiary offices., "The Inc ...
... SAN FRANCISCO, Aug. 28 Medivation, Inc.,(Nasdaq: MDVN ... chief,executive officer, will present at the following conferences:, ... 4, at 9:00 a.m. Eastern Time at the Millennium ... Life Sciences Conference on Wednesday, September 24,at 4:30 p.m. ...
Other Biology Technology:ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 2ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 3ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 4Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US 2Medivation Announces Participation in Upcoming Conferences 2
(Date:12/4/2009)... organs relevant for coronary artery disease (CAD), scientists at ... module of genes that is important for the recruitment ... findings, which are to be published in the open-access ... migration of white blood cells in the development of ...
(Date:12/4/2009)... used by physicians and scientists to study brain function ... largely unknown whether the electrodes on the head give ... brain. Scientists at the Max Planck Institute for Biological ... link between the activity generated within the brain to ...
(Date:12/4/2009)... Using a new mathematical model of heart cells, University ... critical enzyme, calmodulin kinase II (CaM kinase), disrupts the ... study, which also involved Columbia University, was published online ... . , "Recently, researchers have developed great interest ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How to read brain activity? 2U-Iowa study helps advance heart-related research 2Arctic climate under greenhouse conditions in the Late Cretaceous 9187 1Arctic climate under greenhouse conditions in the Late Cretaceous 9187 2Arctic climate under greenhouse conditions in the Late Cretaceous 9187 3European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday July 23 2009 51200 1
... shortening of telomeres, the protective "caps" at the end of ... physical decline. Once they are gone, so are we. But ... Researchers at Salk Institute for Biological Studies demonstrate for the ... trials of old age although its telomeres are still long, ...
... world's vaccine manufacturers will be in a race against ... new technique to more efficiently produce the disarmed viruses ... in large quantities, life-saving inoculations may be available more ... governments worldwide prepare for a predicted pandemic of avian ...
... immune mechanisms kick in to fight them off. The ... protein called HIF-1 alpha regulates this. Interestingly, the cells ... this low-oxygen environment. In a new study appearing in ... Clinical Investigation, Randall Johnson and collegues from UCSD show ...
Other Biology News:Tiny roundworm's telomeres help scientists to tease apart different types of aging 2Tiny roundworm's telomeres help scientists to tease apart different types of aging 3UW scientists report a new method to speed bird flu vaccine production 2UW scientists report a new method to speed bird flu vaccine production 3
...
Human Presenilin-2 NTF Affinity Purified Polyclonal Ab...
2'-Fluorine-CTP (2'-F-CTP) is readily incorporated into transcripts by T7 and SP6 R&DNA™ Polymerase and is available separately....
Human Glypican 2 Biotinylated Affinity Purified PAb...
Biology Products: